242. Genomic Analyses Define a Common Integration Site in Hepatocellular Carcinoma Caused by Therapeutic AAV Gene Delivery: A Mouse-Specific Phenomenon or New Safety Challenge for Human Gene Therapy?

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)35255-8
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Gene Therapy for Hepatocellular Carcinoma.

SEIBUTSU BUTSURI KAGAKU
2000English

Pre-Existing Anti–Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy

Human gene therapy methods
Applied MicrobiologyBiotechnologyGeneticsPharmacologyMolecular Medicine
2013English

Provocative Gene Therapy Strategy for the Treatment of Hepatocellular Carcinoma

Hepatology
MedicineHepatology
1992English

Targeting Therapeutic Vector Expression and Integration for Gene Therapy Applications

English

310. Development of Generation X Recombinant AAV Vectors for Human Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Recombinant Adenovirus Vector-Mediated Human MDA-7 Gene Transfection Suppresses Hepatocellular Carcinoma Growth in a Mouse Xenograft Model

Journal of Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2012English

A Multifunctional Nanocarrier for Efficient TRAIL-based Gene Therapy Against Hepatocellular Carcinoma With Desmoplasia

Hepatology
MedicineHepatology
2018English

HMEJ-mediated Efficient Site-Specific Gene Integration in Chicken Cells

Journal of Biological Engineering
Biomedical EngineeringEnvironmental EngineeringCell BiologyMolecular Biology
2019English

Gene Therapy for Human Glioblastoma Using Neurotropic JC Virus-Like Particles as a Gene Delivery Vector

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy